炎症体
毛螺菌科
磺胺吡啶
脂多糖
肠道菌群
溃疡性结肠炎
促炎细胞因子
免疫印迹
目标2
结肠炎
免疫学
半胱氨酸蛋白酶1
药理学
医学
炎症
微生物学
生物
化学
内科学
生物化学
16S核糖体RNA
疾病
基因
厚壁菌
作者
Xiaodong Li,Xia Wu,Qi Wang,Weilv Xu,Qingwei Zhao,Nana Xu,Xingjiang Hu,Ziqi Ye,Songxia Yu,Jian Liu,Xuelin He,Fushan Shi,Qiao Zhang,Weifen Li
出处
期刊:Phytomedicine
[Elsevier]
日期:2022-07-09
卷期号:104: 154321-154321
被引量:29
标识
DOI:10.1016/j.phymed.2022.154321
摘要
Sanguinarine (SAN) is an important natural anti-inflammatory constitutes and dietary supplementation with SAN could improve the relative length of the intestine, alter gut microbiota, and enhance growth performance of pigs, broiler chickens, and cattle. However, it is unclear whether it has the therapeutic effect on ulcerative colitis (UC). This study aimed to investigate the therapeutic effect of SAN on UC and explore its mechanisms of action. Several efficacy indexes of SAN on dextran sulfate sodium (DSS)-induced C57BL/6 mice were evaluated. ELISA kit and western blot analysis were used to evaluate it's anti-inflammatory effect and the mechanism of action. 16S rDNA sequencing detection was used to determine the impact of SAN on gut microbiota. SAN and Sulfasalazine could significantly improve the colon length, the weight loss, the symptoms and the pathological injury of colon in DSS-induced mice. Meanwhile, SAN could decrease the levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-1β, IL-6, IL-13 and IL-18) and increase the levels of anti-inflammatory cytokines (IL-4 and IL-10) in colon, and suppress DSS-induced high expressions of NLRP3, caspase-1 and IL-1β. In addition, SAN (0.5, 1 μM) could inhibit the expression level of NLRP3 and the activation of caspase-1 and IL-1β in lipopolysaccharide-stimulated THP-1 cells in non-cytotoxic doses, which was similar to that of MCC950, a specific inhibitor of NLRP3 inflammasome activation. The abundance changes of many genera such as Muribaculaceae_unclassified, Escherichia-Shigella, Lachnospiraceae_NK4A136_group and Helicobacter were also closely related to the improvement of SAN on intestinal inflammatory response. SAN exhibited therapeutic effect on DSS-induced colitis by blocking NLRP3-(Caspase-1)/IL-1β pathway and improving intestinal microbial dysbiosis. SAN might be developed to treat UC and other disorders associated with microbial dysbiosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI